Efficacy and safety of sunvozertinib in treatment naive NSCLC patients with EGFR exon20 insertion mutations

被引：0
|
作者：
Xu, Yan
Yang, James Chih-Hsin
Chiu, Chao-Hua
Hsu, Ping-Chih
Mitchell, Paul
Chang, Chia Lun
John, Tom
Bazhenova, Lyudmila
Kim, Tae Min
Yip, Ching Wan
Wang, Mengzhao
Janne, Pasi A.
Zhou, Caicun
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Resp & Crit Care Med, Beijing, Peoples R China
[2] Natl Taiwan Univ Hosp, Taipei, Taiwan
[3] Natl Taiwan Univ Canc Ctr, Taipei, Taiwan
[4] Taipei Vet Gen Hosp, Taipei, Taiwan
[5] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp Linkou, Taoyuan, Taiwan
[6] Austin Hosp, Melbourne, Vic, Australia
[7] Wan Fang Hosp, Taipei, Taiwan
[8] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[9] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92103 USA
[10] Seoul Natl Univ Hosp, Seoul, South Korea
[11] Dizal Pharmaceut, Shanghai, Peoples R China
[12] Dana Farber Canc Inst, Boston, MA 02115 USA
[13] Tongji Univ, Shanghai Pulm Hosp, Sch Med, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9073
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Clinicopathological Characteristics for NSCLC Harboring EGFR Exon 20 Insertion
    Morikawa, K.
    Kakinuma, K.
    Inoue, T.
    Mineshita, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S496 - S496
  • [42] The Prevalence of Different EGFR exon20 Mutations in 12,833 Chinese Lung Cancer Patients
    Shao, Y. W.
    Tong, X.
    Wang, X.
    Wang, F.
    Wu, X.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S495 - S496
  • [43] SUCCESSFUL SUNVOZERTINIB RECHALLENGE FOR ADVANCED LUNG ADENOCARCINOMA WITH HER2 EXON20 INSERTION MUTATION: A CASE REPORT
    Guan, Wenhui
    Jiang, Huixin
    Cao, Jingjing
    Su, Zhihao
    Wu, Ying
    Lin, Xinqing
    Zhou, Chengzhi
    CHEST, 2024, 166 (04) : 4218A - 4219A
  • [44] Clinicopathological Characteristics of 11 NSCLC Patients with EGFR-Exon 20 Mutations
    Lund-Iversen, Marius
    Kleinberg, Lilach
    Fjellbirkeland, Lars
    Helland, Aslaug
    Brustugun, Odd Terje
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : 1471 - 1473
  • [45] Biochemical analysis of EGFR exon20 insertion variants insASV and insSVD and their inhibitor sensitivity
    Zhao, Hanchen
    Beyett, Tyler S.
    Jiang, Jie
    Rana, Jaimin K.
    Schaeffner, Ilse K.
    Santana, Jhasmer
    Janne, Pasi A.
    Eck, Michael J.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2024, 121 (45)
  • [46] Clinical characteristics, treatment patterns and outcomes of EGFR exon 20 insertion and other EGFR mutations in Korean aNSCLC patients
    Yoon, S.
    Lim, S. M.
    Jung, H. A.
    Kim, K-P.
    Kim, D.
    Jeong, H.
    Lim, S.
    Kim, J.
    Kim, J.
    Patel, D.
    Zhao, X.
    Horsburgh, D.
    Yu, D. Y.
    Kim, J. H.
    Kim, S. Y.
    Lee, D. H.
    ANNALS OF ONCOLOGY, 2022, 33 : S56 - S56
  • [47] Optimization of Potent, Efficacious, Selective and Blood-Brain Barrier Penetrating Inhibitors Targeting EGFR Exon20 Insertion Mutations
    Thomson, Clare
    Braybrooke, Erin
    Colclough, Nicola
    Davies, Nichola L.
    Floc'h, Nicolas
    Greenwood, Ryan
    Guerot, Carine
    Hargreaves, David
    Johnstrom, Peter
    Khurana, Puneet
    Kostomiris, Demetrios H.
    Li, Songlei
    Lister, Andrew
    Lorthioir, Olivier
    Martin, Scott
    Mccoull, William
    Mclean, Neville J.
    Mcwilliams, Lisa
    Orme, Jonathan P.
    Packer, Martin J.
    Pearson, Stuart
    Swaih, Aisha M.
    Tentarelli, Sharon
    Tucker, Michael J.
    Ward, Richard A.
    Wilkinson, Stephen
    Winlow, Poppy
    Wood, Isabel L.
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (19) : 17738 - 17773
  • [48] EGFR Exon 20 Insertion Mutations in NSCLC: The Need for Accurate Naming Conventions and Implications for Personalized Therapy
    Park, J.
    Song, J. -Y.
    Sung, M.
    Kwon, M. J.
    Kim, C. R.
    Shin, Y. K.
    Choi, Y. -L.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S484 - S484
  • [49] Real-world treatment outcome of advanced Chinese NSCLC EGFR exon 20 insertion patients.
    Wang, Yan
    Yang, Guangjian
    Li, Jun
    Xu, Haiyan
    Yang, Lu
    Xu, Fei
    Yang, Yaning
    Xia, Bing
    Zhu, Viola Weijia
    Qiu, Weini
    Ou, Sai-Hong Ignatius
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [50] Co-occurring genomic alterations and treatment outcomes in patients with EGFR exon 20 insertion positive NSCLC
    Montenegro, G. Bravo
    Vanderwalde, A.
    Raez, L.
    Nieva, J.
    Feldman, R.
    Herrmann, A.
    Nagasaka, M.
    Ikpeazu, C.
    Mamdani, H.
    Pai, S.
    Wozniak, A.
    Spira, A.
    Lopes, G.
    Liu, S.
    Kim, C.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S605 - S606
12345